Added semaglutide (Ozempic) approved by FDA for prevention and treatment of kidney disease.
Removed Avandia from list of available TZD’s.
Removed indication of metformin as 1st line treatment for diabetes, since the choice of initial agent is based on the individual and presence or absence of CVD, heart failure and degree of kidney disease.
Glucagon PocketCard Teaching Tool
This 2-sided card includes all 4 currently available glucagon treatment options on side one. Side two includes hypoglycemia treatment steps and prevention.
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
Diabetes Blog Bytes
Sign up now to receive the latest Blog Bytes in your inbox.